Abbott, Medtronic and GE Healthcare (A Subsidiary of GENERAL ELECTRIC) are Dominating the Asia-Pacific Electrophysiology Mapping and Ablation Devices Market in 2019

Asia-Pacific Electrophysiology Mapping and Ablation Devices Market is expected to grow with the CAGR of 10.2% in the forecast period of 2020 to 2027. The years considered for study are as mentioned below.

Access Full Report@ https://www.databridgemarketresearch.com/reports/asia-pacific-electrophysiology-mapping-and-ablation-devices-market

Asia-Pacific electrophysiology mapping and ablation devices market is a highly consolidated market, which includes specific number of key players. The market has witnessed increased strategic developments owing to favourable market scenario.   

The major players dealing in electrophysiology mapping and ablation devices market are introducing strong range of products. For instance, In June 2018, Japan Lifeline Co., Ltd. launched the product HeartLight Endoscopic Ablation System and in 2017, this device got the approval from regulatory. HeartLight is a medical device used to treat arrhythmias like atrial fibrillation.  This is helpful in increasing up the revenue and market of the company.

Abbott is the dominating player in electrophysiology mapping and ablation devices market. The other key players existing in the market includes Arthrex, Inc., TORAY INDUSTRIES, INC., Olympus Corporation, Teleflex Incorporated, MicroPort Scientific Corporation, BIOTRONIK, Inc., Boston Scientific Corporation, GE Healthcare (A Subsidiary of GENERAL ELECTRIC), Siemens Healthineers AG, Japan Lifeline Co., Ltd., STARmed Co., Ltd., Koninklijke Philips N.V., Surgnova Healthcare Technologies, Medtronic among others.   

Asia-Pacific Electrophysiology Mapping and Ablation Devices Market

Abbott

Abbott, headquartered in Illinois, U.S. which was founded in 1888. The company focuses on manufacturing and commercializing products and services for healthcare professionals. The company has multiple business segments including pharmaceuticals, nutritionals, diagnostic and medical devices; Medical device is the market focused segment. Company also has wide product portfolio for patients and general public and for healthcare professionals. In this,  healthcare professionals is the market focused category.  

  • In November 2016, Japanese Ministry of Health Labour and Welfare has approved the products of Abbott named EnSite Precision cardiac mapping system and TactiCath irrigated ablation catheter. These technologies gives precised diagnosis and treatment of cardiac arrhythmia as well as atrial fibrillation and helped Abbott to increase its market share and made product portfolio strong.

The company has presence in Asia-Pacific, North America, Europe, South America, Middle East and Africa. The company also has various subsidiary companies such as Abbott Administration, Inc. (Delaware), Abbott Cardiovascular Systems Inc. (California), EAS Australia Pty Ltd (Australia) and among others.

Medtronic  

Medtronic is headquartered in Dublin, Ireland was founded in 1949. The company develops and manufactures a wide range of products and therapies including implantable mechanical devices, drug & biologic delivery devices, and advanced energy surgical instruments. The company has multiple business segments: cardiac and vascular group; minimally invasive therapies group; restorative therapies group; diabetes group; In these cardiac and vascular group, minimally invasive therapies group are the market focused segment.The company is engaged in providing wide range of products category arrhythmia/heart failure, heart and blood vessels, diabetes, ENT, general surgery, brain and nerves, spine and orthopedics, breathing, Icient monitoring, kidney and dialysis, gastrointestinal endoscopy ablation, in these arrhythmia / heart failure,gastrointestinal endoscopy ablation are the market focused category.

  • In January 2019, Medtronic acquired EPIX Therapeutics, Inc. to expand its product portfolio. EPIX Therapeutics, Inc  is involved in development of the catheter-based, temperature-controlled cardiac ablation devices to treat the people with cardiac arrhythmias like atrial fibrillation..

The company has global presence in Americas, Europe, Middle East and Africa, Asia-Pacific.

GE Healthcare ( A Subsidiary of GENERAL ELECTRIC)

GE Healthcare ( A Subsidiary of GENERAL ELECTRIC) headquartered in Illinois, U.S. was founded in 1994. The company mainly focuses in the pursuit of precision health along with improved outcomes for healthcare providers and for therapy innovators around the world. Company also has wide product portfolio in accessories and supplies, advanced visualization, anesthesia delivery, bone and metabolic health, computed tomography, contrast media, diagnostic ecg, edison, ep recording, goldseal-refurbished systems, healthcare it, hemodynamic recording, interoperability, interventional image guided systems, life sciences, magnetic resonance imaging, mammography, maternal infant care, molecular imaging, nuclear imaging agents, patient monitoring, radiography, fluoroscopy systems, surgical imaging, ultrasound, ventilators; In this interventional image guided systemis the market focused product category.

The company has presence in Asia-Pacific, Europe, Middle East and Africa,  North America, South America. The company also has various subsidiary companies such as Biacore (Sweden), GE Healthcare Dharmacon, Inc.(U.S.), Nihon Medi-Physics Co.,Ltd.(Japan), Medi-Physics, Inc.(U.S.), Hyclone Laboratories Inc(U.S.), Biosafe SA (Switzeland), ONI Medical Systems(U.S.) and Wipro GE Healthcare Pvt. Ltd.(India) among others.